Newsroom
Announcements, portfolio news, and insights from IBC.
Stay current with leadership updates, funding milestones, and progress from the companies building the future of immune-mediated disease treatment.
Featured
June 18, 2026Research
ANRF Announces Largest Scholar Cohort and Research Investment in Foundation History
Veteran biotech investor Dr. Sai Nandi joins IBC as Fund Principal to lead the expansion of the firm's venture fund and oversee its investment strategy in early-stage therapeutics, diagnostics, and enabling technologies for immune disorders.
Arthritis National Research FoundationRead full announcement
April 8, 2026Leadership
Immune Boost Capital Appoints Dr. Sai Nandi to Head Impact Investment Fund Targeting Immune-Mediated Diseases
Veteran biotech investor Dr. Sai Nandi joins IBC as Fund Principal to lead the expansion of the firm's venture fund and oversee its investment strategy in early-stage therapeutics, diagnostics, and enabling technologies for immune disorders.
Arthritis National Research FoundationRead full announcement
More stories coming soon.
As we make new investments and share updates from our portfolio, you'll find those announcements here.